Literature DB >> 23563640

Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.

Xiao-Dong Sun1, Xing-E Liu, Dong-Sheng Huang.   

Abstract

Curcumin, a phenolic compound extracted from Zingiberaceae turmeric, has strong anti-inflammatory, antioxidant and antitumor properties. However, the anticarcinogenic mechanism of curcumin has yet to be fully elucidated. Epithelial-mesenchymal transition (EMT) induced by transforming growth factor-β1 (TGF-β1) is involved in the promotion of tumor invasion and metastasis, and is closely related to the drug resistance of tumor cells. The abnormal activation of Hedgehog signaling also plays an important role in tumorigenesis and metastasis. In order to investigate whether curcumin can reverse the TGF-β1-stimulated EMT of pancreatic cancer PANC-1 cells, and its possible mechanism, the pancreatic cancer cell line PANC-1 was stimulated with TGF-β1 (5 ng/ml) for 7 days to induce formation of EMT, and the TGF-β1-stimulated PANC-1 cells were treated with different concentrations of curcumin (10, 20 and 30 µmol/ml) for 48 h. The growth inhibition rate of the cells was measured by MTT assay, apoptosis was detected by flow cytometry, the expression levels of Shh, GLI1, E-cadherin and vimentin were detected by western blot analysis, and cell invasion and migration ability were examined by transwell cell invasion assay and wound healing assay. Following stimulation with TGF-β1, the expression levels of Shh, GLI1 and vimentin in the TGF-β1-stimulated group were significantly increased, compared with those in the control group (P<0.01, respectively). The expression levels of E-cadherin in the TGF-β1-stimulated group were significantly decreased, compared with those in the control group (P<0.01). The TGF-β1-stimulated PANC-1 cells were treated with curcumin and the results showed that curcumin significantly inhibited TGF-β1-stimulated PANC-1 cell proliferation and induced apoptosis, compared with other groups (P<0.01), and the expression levels of Shh, GLI1 and vimentin in the curcumin-treated group were significantly decreased compared with those in the control group (P<0.01, respectively). The expression level of E-cadherin in the curcumin-treated group was significantly increased compared with that in the control group (P<0.01). Cell invasion in the curcumin-treated group (30 µmol/ml) was significantly decreased compared with that in the control group (P<0.01). The scratch wounds in the curcumin-treated group healed slower compared with those in the control group (P<0.01). Curcumin significantly inhibited the invasion and migration of TGF-β1-stimulated PANC-1 cells. These results indicate that curcumin can inhibit the proliferation of TGF-β1-stimulated PANC-1 cells, it can induce apoptosis, and reverse the EMT. The possible underlying molecular mechanisms are through inhibition of the Shh-GLI1 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563640     DOI: 10.3892/or.2013.2385

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  42 in total

Review 1.  Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.

Authors:  Juanita L Merchant; Milena Saqui-Salces
Journal:  Cancer Treat Rev       Date:  2013-08-13       Impact factor: 12.111

2.  Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling.

Authors:  Abdalkareem Omar Maghmomeh; Amal Mohamed El-Gayar; Amro El-Karef; Noha Abdel-Rahman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-14       Impact factor: 3.000

3.  Curcumin regulates cell fate and metabolism by inhibiting hedgehog signaling in hepatic stellate cells.

Authors:  Naqi Lian; Yuanyuan Jiang; Feng Zhang; Huanhuan Jin; Chunfeng Lu; Xiafei Wu; Yin Lu; Shizhong Zheng
Journal:  Lab Invest       Date:  2015-05-04       Impact factor: 5.662

4.  Combination treatment with dendrosomal nanocurcumin and doxorubicin improves anticancer effects on breast cancer cells through modulating CXCR4/NF-κB/Smo regulatory network.

Authors:  Mohammad Amin Mahjoub; Babak Bakhshinejad; Majid Sadeghizadeh; Sadegh Babashah
Journal:  Mol Biol Rep       Date:  2017-07-27       Impact factor: 2.316

Review 5.  Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.

Authors:  Hideya Onishi; Mitsuo Katano
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 6.  Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer.

Authors:  Dharmalingam Subramaniam; Gaurav Kaushik; Prasad Dandawate; Shrikant Anant
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

7.  Nectin-1 expression in cancer-associated fibroblasts is a predictor of poor prognosis for pancreatic ductal adenocarcinoma.

Authors:  Misuzu Yamada; Kenichi Hirabayashi; Aya Kawanishi; Atsuko Hadano; Yumi Takanashi; Hideki Izumi; Yoshiaki Kawaguchi; Tetsuya Mine; Naoya Nakamura; Toshio Nakagohri
Journal:  Surg Today       Date:  2017-12-18       Impact factor: 2.549

8.  Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway.

Authors:  Zhang Ke; Sun Caiping; Zhang Qing; Wang Xiaojing
Journal:  Med Oncol       Date:  2014-11-29       Impact factor: 3.064

Review 9.  Targeting E-cadherin expression with small molecules for digestive cancer treatment.

Authors:  Yizuo Song; Miaomiao Ye; Junhan Zhou; Zhiwei Wang; Xueqiong Zhu
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

10.  Casticin inhibits the epithelial-mesenchymal transition in ovarian carcinoma via the hedgehog signaling pathway.

Authors:  Jing Zhang; Yinghong Cui; Shuwen Sun; Jianguo Cao; Xiaoling Fang
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.